Valerio Iebba Selected Research

Therapeutics

1/2023	Faecal microbiota composition is related to response to CDK4/6-inhibitors in metastatic breast cancer: A prospective cross-sectional exploratory study.
1/2022	Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis.
1/2021	Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment.
1/2020	High abundance of genus Prevotella is associated with dysregulation of IFN-I and T cell response in HIV-1-infected patients.
1/2020	Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage.
1/2020	Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients.
12/2014	Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Valerio Iebba Research Topics

Disease

7	Neoplasms (Cancer) 01/2022 - 01/2020
5	Dysbiosis 01/2022 - 12/2014
4	Cystic Fibrosis (Mucoviscidosis) 04/2018 - 04/2010
2	Carcinogenesis 01/2023 - 01/2022
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2020
2	Inflammation (Inflammations) 01/2021 - 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Colitis 01/2023
1	Ulcerative Colitis 01/2023
1	Atrophy 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	COVID-19 01/2021
1	Weight Gain 01/2021
1	Infertility (Sterility) 12/2020
1	Kidney Neoplasms (Kidney Cancer) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Microsatellite Instability 01/2020
1	Clostridium Infections 10/2019
1	Malnutrition (Nutritional Deficiencies) 12/2016
1	Hepatic Encephalopathy 12/2016
1	Salivary Calculi (Salivary Calculus) 03/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2014
1	Infections 01/2014
1	Crohn Disease (Crohn's Disease) 04/2012
1	Celiac Disease (Celiac Sprue) 06/2010

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
2	Peptides (Polypeptides)IBA 01/2023 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 12/2016 - 04/2012
1	Hormones (Hormone)IBA 01/2023
1	MutagensIBA 01/2023
1	CyclinsIBA 01/2023
1	cyclosporin HIBA 01/2023
1	AzoxymethaneIBA 01/2023
1	human ERBB2 proteinIBA 01/2023
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2023
1	Sulindac (Copal)FDA LinkGeneric 01/2023
1	Detergents (Detergent)IBA 01/2023
1	Dextrans (Dextran)FDA Link 01/2023
1	Vancomycin FDA LinkGeneric 01/2022
1	Propranolol (Inderal)FDA LinkGeneric 01/2022
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2022
1	Cholinergic Agents (Cholinergics)IBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	CytokinesIBA 01/2021
1	KetonesIBA 01/2021
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	16S Ribosomal RNAIBA 01/2021
1	Culture MediaIBA 12/2020
1	AntigensIBA 01/2020
1	Thymidine Monophosphate (TMP)IBA 01/2020
1	Therapeutic UsesIBA 04/2018
1	CalciumIBA 03/2016
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2013
1	Mannose (D-Mannose)IBA 04/2012
1	Glutens (Glutelin)IBA 06/2010
1	DNA (Deoxyribonucleic Acid)IBA 04/2010

Therapy/Procedure

7	Therapeutics 01/2023 - 12/2014
4	Drug Therapy (Chemotherapy) 01/2023 - 01/2020
2	Immunotherapy 01/2021 - 01/2020
1	Chemoradiotherapy 01/2023
1	Ketogenic Diet 01/2021
1	Transplantation 10/2019